Skip to main navigation
Skip to search
Skip to main content
SUNY University at Buffalo Home
Help & FAQ
!!Link opens in a new tab
!!Search content at SUNY University at Buffalo
Home
Profiles
Research units
Facilities & Equipment
Grants & Projects
Research output
Prizes
Activities
Skyscraper: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Of Atezolizumab with or without Tiragolumab (Anti-Tigit Antibody) in Patients with Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Pili, Roberto
(CoI)
Goueli, Basem
(PI)
University At Buffalo
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
09/1/20
→
12/31/25
Funding
Syneos Health Limited Liability Company:
$189,836.02
View all
View less